Evofem Biosciences, Inc. (EVFM) intrinsic value & 10-year financials
Evofem Biosciences, Inc. (EVFM) has a Graham intrinsic value of $0.02 per share. At $0.01 on Oct 17, 2026, the stock trades 50% below that value. Over the last 10 fiscal years revenue grew 114.3% a year to $20.2M, with an average return on invested capital of -7977.6%.
- Graham intrinsic value
- $0.02
- Share price (Oct 17, 2026)
- $0.01
- Price vs Graham value
- 50% below
- Market cap
- $40.5M
- Revenue (FY2025)
- $20.2M
- Revenue growth (10-yr CAGR)
- 114.3%
- ROIC (10-yr avg)
- -7977.6%
- Free cash flow (FY2025)
- -$2.0M
EVFM 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $20.2M | $391.0K | $0.00 | -$2.0M | 16.7% | -4.6% |
| FY2024 | $19.4M | -$8.9M | -$0.00 | -$3.9M | -39.6% | 12.8% |
| FY2023 | $18.2M | $53.0M | $0.00 | -$9.0M | -98.0% | 25.8% |
| FY2022 | $16.8M | -$76.7M | -$0.00 | -$70.8M | -499.6% | 94.0% |
| FY2021 | $8.2M | -$205.2M | -$0.00 | -$149.6M | -2023.3% | 223.7% |
| FY2020 | $446.0K | -$142.3M | -$0.00 | -$107.1M | -23234.1% | 500.0% |
| FY2019 | $0 | -$80.0M | — | -$55.3M | — | -81141.5% |
| FY2018 | — | -$125.7M | — | -$56.5M | — | 752.0% |
| FY2017 | — | -$10.0M | — | -$8.2M | — | -137.4% |
| FY2016 | — | -$13.0M | — | — | — | -101.1% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Evofem Biosciences, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Evofem Biosciences, Inc. has historically struggled to out-earn its cost of capital, averaging just -90.7% ROIC.
Evofem Biosciences, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Evofem Biosciences, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.02 per share.